Role of the endocannabinoid system in MDMA intracerebral self-administration in rats

被引:49
作者
Braida, D [1 ]
Sala, M [1 ]
机构
[1] Univ Milan, Dept Pharmacol Chemotherapy & Med Toxicol, Fac Math Phys & Nat Sci, I-20129 Milan, Italy
关键词
3,4 methylenedioxymethamphetamine; CP 55,940; SR; 141716A;
D O I
10.1038/sj.bjp.0704825
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
I.c.v. self-administration of MDMA (0.01 - 2 mug per infusion), alone and in combination with CP 55,940 (0.4 mug infusion(-1)), was studied on an operant responding procedure. On the basis of individual preference for one of two levers, developed during training, rats were allowed to self-administer vehicle from the preferred lever and MDMA from the other. Pressings on the MDMA associated-lever, except for the maximal unit dose, progressively increased. The combination of CP 55,940 with MDMA (1 mug infusion(-1)) reduced the number of drug-associated lever pressings compared to the single drugs. Pre-treatment with SR 141716A (0.5 mg kg(-1) i.p.), 15 min before each daily session, significantly increased MDMA self-administration. These findings suggest that MDMA self-administration is under endogenous tonic control by the endocannabinoid system.
引用
收藏
页码:1089 / 1092
页数:4
相关论文
共 23 条
[1]   Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats [J].
Arnold, JC ;
Hunt, GE ;
McGregor, LS .
LIFE SCIENCES, 2001, 70 (01) :97-108
[2]   SELF-ADMINISTRATION OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA) BY RHESUS-MONKEYS [J].
BEARDSLEY, PM ;
BALSTER, RL ;
HARRIS, LS .
DRUG AND ALCOHOL DEPENDENCE, 1986, 18 (02) :149-157
[3]   METHYLENEDIOXYMETHAMPHETAMINES CAPACITY TO ESTABLISH PLACE PREFERENCES AND MODIFY INTAKE OF AN ALCOHOLIC BEVERAGE [J].
BILSKY, EJ ;
HUI, YZ ;
HUBBELL, CL ;
REID, LD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) :633-638
[4]   A novel method for self-administering addicting drugs intracerebroventricularly in a free-choice procedure [J].
Braida, D ;
Virag, W ;
Ottonello, F ;
Inghilterra, S ;
Gori, E ;
Sala, M .
BRAIN RESEARCH PROTOCOLS, 1998, 3 (02) :135-141
[5]   Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system [J].
Braida, D ;
Pozzi, M ;
Parolaro, D ;
Sala, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 413 (2-3) :227-234
[6]   Conditioned place preference induced by the cannabinoid agonist CP 55,940: Interaction with the opioid system [J].
Braida, D ;
Pozzi, M ;
Cavallini, R ;
Sala, M .
NEUROSCIENCE, 2001, 104 (04) :923-926
[7]   Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse [J].
Cossu, G ;
Ledent, C ;
Fattore, L ;
Imperato, A ;
Böhme, GA ;
Parmentier, M ;
Fratta, W .
BEHAVIOURAL BRAIN RESEARCH, 2001, 118 (01) :61-65
[8]   The relative contributions of ecstasy and cannabis to cognitive impairment [J].
Croft, RJ ;
Mackay, AJ ;
Mills, ATD ;
Gruzelier, JGH .
PSYCHOPHARMACOLOGY, 2001, 153 (03) :373-379
[9]   A cannabinoid mechanism in relapse to cocaine seeking [J].
De Vries, TJ ;
Shaham, Y ;
Homberg, JR ;
Crombag, H ;
Schuurman, K ;
Dieben, J ;
Vanderschuren, LJMJ ;
Schoffelmeer, ANM .
NATURE MEDICINE, 2001, 7 (10) :1151-1154
[10]   SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats [J].
Deroche-Gamonet, V ;
Le Moal, M ;
Piazza, PV ;
Soubrié, P .
PSYCHOPHARMACOLOGY, 2001, 157 (03) :254-259